With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.166330-10-5,(Oxybis(2,1-phenylene))bis(diphenylphosphine),as a common compound, the synthetic route is as follows.
The terminating ligand dpepo was obtained by oxidizing the precursor DPEphos (diepiii phosph) with hydrogen peroxide., 166330-10-5
166330-10-5 (Oxybis(2,1-phenylene))bis(diphenylphosphine) 4285986, achiral-phosphine-ligands compound, is more and more widely used in various fields.
Reference£º
Patent; HOKKAIDO UNIVERSITY; STANLEY ELECTRIC COMPANY LIMITED; OSAKA PREFECTURE UNIVERSITY; HASEGAWA, YASUCHIKA; NATORI, SHIORI; NAKANISHI, TAKAYUKI; KITAGAWA, YUICHI; FUSHIMI, KOJI; AKAGI, TSUTOMU; NAITO, HIROYOSHI; FUKUDOME, JUN; (32 pag.)JP2018/35101; (2018); A;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate